Abstract
Background: Osteosarcoma (OS) is the most prevalent malignant primary bone tumor in children. Selectin P ligand gene (SELPLG) has been studied in several cancers. Our research aimed to explore the role of SELPLG in OS. Methods: All OS patient data was obtained from TARGET and GEO databases. Differential expression analyses were conducted in limma package of R. Functional analyses included GO and KEGG enrichment analyses. Immune cell infiltration analysis was done in CIBERSORT software. The overall survival was calculated using survival and survminer package of R. Results: Significantly lower SELPLG expression was observed in metastatic OS samples compared with non-metastatic OS samples, both in TARGET and in GSE21257. Low SELPLG expression was an independent undesirable prognostic factor for OS patients, in both TARGET and GEO datasets. Totally 62 differentially expressed gene (DEG) overlaps were found between high SELPLG vs. low SELPLG and non-metastatic vs. metastatic OS samples, affecting metastases and thereby influencing the prognosis, which were significantly enriched in 40 GO and six KEGG terms. Five types of immune cells were significantly differentially infiltrated between high and low SELPLG expression OS patients. Conclusion: SELPLG is closely correlated with metastases and prognosis of OS patients. The OS patients with low SELPLG expression have relatively poorer prognosis and SELPLG is a potential prognostic biomarker for OS.
Highlights
Osteosarcoma (OS), as an aggressive tumor in skeletal system, is the most prevalent malignant primary bone tumor in children, young adults and the elders [1]
The survival rates of non-metastatic OS patients have significantly increased to 65–75% [3], but the overall 5-years survival rate of Abbreviations: OS, osteosarcoma; Selectin P ligand gene (SELPLG), selectin P ligand gene; ARDS, acute respiratory distress syndrome; AML, acute myeloid leukemia; CRC, colorectal cancer; HNSCC, head and neck squamous cell carcinoma; ALCL, anaplastic large T-cell lymphoma; TARGET, therapeutically applicable research to generate effective treatments; Gene Expression Omnibus (GEO), gene expression omnibus; DEGs, differentially expressed genes; BP, biological process; MF, molecular function; CC, cellular component; MSCs, mesenchymal stem cells
Our results suggested that low SELPLG expression might be related to the metastases of OS
Summary
Osteosarcoma (OS), as an aggressive tumor in skeletal system, is the most prevalent malignant primary bone tumor in children, young adults and the elders [1]. The survival rates of non-metastatic OS patients have significantly increased to 65–75% [3], but the overall 5-years survival rate of Abbreviations: OS, osteosarcoma; SELPLG, selectin P ligand gene; ARDS, acute respiratory distress syndrome; AML, acute myeloid leukemia; CRC, colorectal cancer; HNSCC, head and neck squamous cell carcinoma; ALCL, anaplastic large T-cell lymphoma; TARGET, therapeutically applicable research to generate effective treatments; GEO, gene expression omnibus; DEGs, differentially expressed genes; BP, biological process; MF, molecular function; CC, cellular component; MSCs, mesenchymal stem cells. Osteosarcoma (OS) is the most prevalent malignant primary bone tumor in children. Our research aimed to explore the role of SELPLG in OS
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
